特应性皮炎相关细胞因子对皮肤屏障的影响

doi:10.3760/cma.j.issn.0412-4030.2019.01.016

Abstract

Abstract: 【Abstract】 The skin is the largest organ of the human body, and is an important barrier. There is dysfunction of skin barrier in patients with atopic dermatitis （AD）, and the composition of cytokines in patients with AD is different from healthy persons. Many cytokines found in the skin of AD patients can affect the differentiation and cornification of keratinocytes. This review summarizes the latest advances in AD-related cytokines and their effect on skin barrier function. These results are helpful to understand the pathogenesis of AD, and may provide new directions for the treatment of AD.

Key words: Dermatitis, atopic, Interleukins, Cytokines, Skin barrier

Zhang Nan, Wang Lian, Liu Lian, Zhang Zihui, Jiang Xian. Effect of atopic dermatitis-related cytokines on skin barrier[J]. Chinese Journal of Dermatology, 2019, 52(1): 46-49.doi:10.3760/cma.j.issn.0412-4030.2019.01.016

References ［38］

［1］	Mu Z, Zhao Y, Liu X, et al. Molecular biology of atopic dermatitis［J］. Clin Rev Allergy Immunol, 2014,47（2）:193⁃218. doi: 10.1007/ s12016⁃014⁃8415⁃1.
［2］	Noda S, Suárez⁃Fariñas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization［J］. J Allergy Clin Immunol, 2015,136（5）:1254⁃1264. doi: 10.1016/j.jaci.2015.08. 015.
［3］	Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a CLA+ TH2/TH1 imbalance, while adults acquire CLA+ TH22/TC22 subsets［J］. J Allergy Clin Immunol, 2015,136（4）:941⁃951.e3. doi: 10.1016/j.jaci.2015.05.049.
［4］	Czarnowicki T, Gonzalez J, Shemer A, et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin⁃homing T⁃cell population［J］. J Allergy Clin Immunol, 2015,136（1）:104⁃115.e7. doi: 10.1016/j.jaci.2015.01.020.
［5］	Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march［J］. J Allergy Clin Immunol, 2016,138（2）:350⁃358.e1. doi: 10. 1016/j.jaci.2016.06.002.
［6］	Deraison C, Bonnart C, Lopez F, et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH⁃dependent interaction［J］. Mol Biol Cell, 2007,18（9）:3607⁃3619. doi: 10.1091/mbc.e07⁃02⁃0124.
［7］	Abhishek S, Palamadai KS. Epidermal differentiation complex: a review on its epigenetic regulation and potential drug targets[J]. Cell J, 2016,18（1）:1⁃6. doi: 10.22074/cellj.2016.3980.
［8］	Danso MO, van Drongelen V, Mulder A, et al. TNF⁃α and Th2 cytokines induce atopic dermatitis⁃like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents［J］. J Invest Dermatol, 2014,134（7）:1941⁃1950. doi: 10.1038/jid.2014.83.
［9］	Di ZH, Ma L, Qi RQ, et al. T helper 1 and T helper 2 cytokines differentially modulate of filaggrin and its processing proteases in human keratinocytes［J］. Chin Med J （Engl）, 2016,129（3）:295⁃303. doi: 10.4103/0366⁃6999.174489.
［10］	Sawada E, Yoshida N, Sugiura A, et al. Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis［J］. J Dermatol Sci, 2012,68（1）:25⁃35. doi: 10.1016/j.jdermsci.2012.07.004.
［11］	Morizane S, Yamasaki K, Kajita A, et al. TH2 cytokines increase kallikrein 7 and function in patients with atopic dermatitis［J］. J Allergy Clin Immunol, 2012,130（1）:259⁃261.e1. doi: 10.1016/j.jaci.2012.03.006.
［12］	Hatano Y, Adachi Y, Elias PM, et al. The Th2 cytokine, interleukin⁃4, abrogates the cohesion of normal stratum corneum in mice: implications for pathogenesis of atopic dermatitis［J］. Exp Dermatol, 2013,22（1）:30⁃35. doi: 10.1111/exd.12047.
［13］	Lee UH, Kim BE, Kim DJ, et al. Atopic dermatitis is associated with reduced corneodesmosin : role of cytokine modu⁃lation and effects on viral penetration［J］. Br J Dermatol, 2017,176（2）:537⁃540. doi: 10.1111/bjd.15010.
［14］	Fujii⁃Maeda S, Kajiwara K, Ikizawa K, et al. Reciprocal regulation of thymus and activation⁃regulated chemokine/macrophage⁃derived chemokine production by interleukin （IL）⁃4/IL⁃13 and interferon⁃gamma in HaCaT keratinocytes is mediated by alternations in E⁃cadherin distribution［J］. J Invest Dermatol, 2004,122（1）:20⁃28. doi: 10.1046/j.0022⁃202X.2003.22103.x.
［15］	Gruber R, Börnchen C, Rose K, et al. Diverse regulation of claudin⁃1 and claudin⁃4 in atopic dermatitis［J］. Am J Pathol, 2015,185（10）:2777⁃2789. doi: 10.1016/j.ajpath.2015.06.021.
［16］	Doran E, Cai F, Holweg CTJ, et al. Interleukin⁃13 in asthma and other eosinophilic disorders[J]. Front Med （Lausanne）, 2017,4:139. doi: 10.3389/fmed.2017.00139.
［17］	Amano W, Nakajima S, Kunugi H4, et al. The Janus kinase inhibitor JTE⁃052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling［J］. J Allergy Clin Immunol, 2015,136（3）:667⁃677.e7. doi: 10.1016/j.jaci.2015.03.051.
［18］	Bao L, Mohan GC, Alexander JB, et al. A molecular mechanism for IL⁃4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis［J］. Innate Immun, 2017,23（8）:641⁃647. doi: 10.1177/175342591773 2823.
［19］	Kim JH, Bae HC, Ko NY, et al. Thymic stromal lymphopoietin downregulates filaggrin by signal transducer and activator of transcription 3 （STAT3） and extracellular signal⁃regulated kinase （ERK） phosphorylation in keratinocytes［J］. J Allergy Clin Immunol, 2015,136（1）:205⁃208.e9. doi: 10.1016/j.jaci.2015.04.026.
［20］	Wang FP, Tang XJ, Wei CQ, et al. Dupilumab treatment in moderate⁃to⁃severe atopic dermatitis: a systematic review and meta⁃analysis［J］. J Dermatol Sci, 2018,90（2）:190⁃198. doi: 10. 1016/j.jdermsci.2018.01.016.
［21］	Saleem MD1, Oussedik E1, D'Amber V, et al. Interleukin⁃31 pathway and its role in atopic dermatitis: a systematic review［J］. J Dermatolog Treat, 2017,28（7）:591⁃599. doi: 10.1080/09546634.2017.1290205.
［22］	Hänel KH, Pfaff CM, Cornelissen C, et al. Control of the physical and antimicrobial skin barrier by an IL⁃31⁃IL⁃1 signaling network［J］. J Immunol, 2016,196（8）:3233⁃3244. doi: 10.4049/jimmunol. 1402943.
［23］	Singh B, Jegga AG, Shanmukhappa KS, et al. IL⁃31⁃driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin⁃barrier function［J］. PLoS One, 2016,11（8）:e0161877. doi: 10.1371/journal.pone.016 1877.
［24］	Ungar B, Garcet S, Gonzalez J, et al. An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease［J］. J Invest Dermatol., 2017,137（3）:603⁃613. doi: 10.1016/j.jid.2016.09.037.
［25］	Wolk K, Haugen HS, Xu W, et al. IL⁃22 and IL⁃20 are key mediators of the epidermal alterations in psoriasis while IL⁃17 and IFN⁃gamma are not［J］. J Mol Med （Berl）, 2009,87（5）:523⁃536. doi: 10.1007/s00109⁃009⁃0457⁃0.
［26］	Wolk K, Witte E, Wallace E, et al. IL⁃22 regulates the of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis［J］. Eur J Immunol, 2006,36（5）:1309⁃1323. doi: 10.1002/ eji.200535503.
［27］	Boniface K, Bernard FX, Garcia M, et al. IL⁃22 inhibits epidermal differentiation and induces proinflammatory gene and migration of human keratinocytes［J］. J Immunol, 2005,174（6）:3695⁃3702.
［28］	Lou H, Lu J, Choi EB, et al. Expression of IL⁃22 in the skin causes Th2⁃biased immunity, epidermal barrier dysfunction, and pruritus via stimulating epithelial Th2 cytokines and the GRP pathway［J］. J Immunol, 2017,198（7）:2543⁃2555. doi: 10. 4049/jimmunol.1600126.
［29］	Tawada C, Kanoh H, Nakamura M, et al. Interferon⁃γ decreases ceramides with long⁃chain fatty acids: possible involvement in atopic dermatitis and psoriasis［J］. J Invest Dermatol, 2014,134（3）:712⁃718. doi: 10.1038/jid.2013.364.
［30］	Guttman⁃Yassky E, Krueger JG. Atopic dermatitis and psoriasis: two different immune diseases or one spectrum?［J］. Curr Opin Immunol, 2017,48:68⁃73. doi: 10.1016/j.coi.2017.08.008.
［31］	Floudas A, Saunders SP, Moran T, et al. IL⁃17 receptor A maintains and protects the skin barrier to prevent allergic skin inflammation［J］. J Immunol, 2017,199（2）:707⁃717. doi: 10.4049/jimmunol.1602185.
［32］	Pfaff CM, Marquardt Y, Fietkau K, et al. The psoriasis⁃associated IL⁃17A induces and cooperates with IL⁃36 cytokines to control keratinocyte differentiation and function［J］. Sci Rep, 2017,7（1）:15631. doi: 10.1038/s41598⁃017⁃15892⁃7.
［33］	Gutowska⁃Owsiak D, Schaupp AL, Salimi M, et al. IL⁃17 downregulates filaggrin and affects keratinocyte of genes associated with cellular adhesion［J］. Exp Dermatol, 2012,21（2）:104⁃110. doi: 10.1111/j.1600⁃0625.2011.01412.x.
［34］	Yuki T, Tobiishi M, Kusaka⁃Kikushima A, et al. Impaired tight junctions in atopic dermatitis skin and in a skin⁃equivalent model treated with interleukin⁃17［J］. PLoS One, 2016,11（9）:e0161759. doi: 10.1371/journal.pone.0161759.
［35］	Hvid M, Vestergaard C, Kemp K, et al. IL⁃25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction?［J］. J Invest Dermatol, 2011,131（1）:150⁃157. doi: 10.1038/jid.2010.277.
［36］	Nygaard U, van den Bogaard EH, Niehues H, et al. The "alarmins" HMBG1 and IL⁃33 downregulate structural skin barrier proteins and impair epidermal growth［J］. Acta Derm Venereol, 2017,97（3）:305⁃312. doi: 10.2340/00015555⁃2552.
［37］	Seltmann J, Roesner LM, von HFW, et al. IL⁃33 impacts on the skin barrier by downregulating the of filaggrin［J］. J Allergy Clin Immunol, 2015,135（6）:1659⁃1661.e4. doi: 10.1016/ j.jaci.2015.01.048.
［38］	Snast I, Reiter O, Hodak E, et al. Are biologics efficacious in atopic dermatitis? A systematic review and meta⁃analysis［J］. Am J Clin Dermatol, 2018,19（2）:145⁃165. doi: 10.1007/s40257⁃017⁃0324⁃7.

[1]	Chen Chunli, Yan Siyu, Wang Dan, Gao Lihua, Tan Lina, Tang Siyuan, Liu Wei, Zeng Jinrong, Lu Jianyun, . Efficacy of acidified aliphatic ester in the treatment of atopic dermatitis in mouse models and preliminary exploration of its mechanisms of action [J]. Chinese Journal of Dermatology, 2023, 56(9): 822-831.
[2]	Zhao Ying, Zhang Xiaoyan, Chen Lu, Su Yuhua, Ding Yujie, Leng Hong, Ji Jiang. Predictive factors for the efficacy of omalizumab in the treatment of refractory chronic spontaneous urticaria [J]. Chinese Journal of Dermatology, 2023, 56(1): 22-28.
[3]	Lu Xiaoyun, Zhang Zengyunou, Xiao Fengli. Role of epithelium-derived cytokines interleukin-33, interleukin-25 and thymic stromal lymphopoietin in the pathogenesis of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(6): 548-551.
[4]	Huang Yaxin, He Yuanmin, Huang Shuli, Xiong Xia, Deng Yongqiong. An investigation into clinical significance of serum chitinase 3-like protein 1 in pemphigus vulgaris [J]. Chinese Journal of Dermatology, 2022, 55(6): 523-527.
[5]	Wang Ao, Yao Xu. Mechanisms of pruritus in atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 357-361.
[6]	Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.
[7]	Zhao Peng, Qin Xiaowei, Qin Junxia, Liang Lili, Zhang Xinzhong, Gao Jie. Expression of peripheral interleukin-35 and its modulatory effect on regulatory T cell functions in patients with alopecia areata [J]. Chinese Journal of Dermatology, 2022, 55(3): 224-230.
[8]	Xie Xiaoyuan, Liu Fang, Chen Huan, Xu Jie, Kong Qingtao, Sang Hong. A preliminary study on the relationship between in vivo metal implants and acquired palmoplantar keratodermas [J]. Chinese Journal of Dermatology, 2022, 55(10): 869-873.
[9]	Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75.
[10]	Zhang Haini, Kou Caixia, Liu Jinquan, Zhang Ruihua, Ma Yinni, Zhang Ruili, Wang Qianqiu. Inductive effect of Treponema pallidum on macrophage polarization [J]. Chinese Journal of Dermatology, 2021, 54(8): 688-695.
[11]	Yang Ting, Zhang Kaoyuan, Li Zizhuo, Li Xu, Yu Bo, Dou Xia. Role of group 2 innate lymphoid cells in mice with atopic dermatitis-like inflammatory response induced by MC903 [J]. Chinese Journal of Dermatology, 2021, 54(4): 335-341.
[12]	Hu Yuqing, Liu Ping, Mu Zhanglei, Zhang Jianzhong . Effect of benvitimod on the proliferation of, inflammatory cytokine secretion by and skin barrier factor production by HaCaT cells [J]. Chinese Journal of Dermatology, 2020, 53(12): 984-991.
[13]	Fu Dandan , Hu Hua, Zhang Mengjie, Li Min, Li Zhanguo, Tian Zhongwei. Effect of epigallocatechin gallate on Th1/Th2 immune balance in patients with plaque?type psoriasis [J]. Chinese Journal of Dermatology, 2019, 52(9): 611-615.
[14]	Su Beibei, Gan Quan, Gan Caibin. Effects of metformin on inflammatory status and phosphorylated Stat3 expression in lesions of a psoriasis?like mouse model [J]. Chinese Journal of Dermatology, 2019, 52(7): 475-480.
[15]	Cao Ke, Hou Xiaoxiao, Li Xin, Christos C. Zouboulis, Ju Qiang. Effect of isotretinoin on peptidoglycan-induced expression of inflammatory genes in human SZ95 sebocytes [J]. Chinese Journal of Dermatology, 2019, 52(4): 248-252.

Effect of atopic dermatitis-related cytokines on skin barrier

PDF

Knowledge

Abstract

Cite this article

share this article

References ［38］

Related Articles 15

Metrics

Comments

Recommended 10